IL2 and neoplasm: Several studies have investigated IL-2 as a T cell growth factor that induce Fas-mediated elimination of Tregs and MDSCs from the tumor microenvironment and elicit synergistic antitumor responses coincident with the efficient removal of Tregs and MDSCs in cancer models [31].